New insulin pump system tested for safety in toddlers and preschoolers with diabetes
NCT ID NCT06604871
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the MiniMed 780G insulin pump, when used with a continuous glucose monitor, is safe for children aged 2 to 6 years with type 1 diabetes. Fifty-six children used the system at home. The main goals were to measure how often their blood sugar stayed in a healthy range and to track any serious side effects like severe low blood sugar or diabetic ketoacidosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MiniMed 780G insulin pump with DS5 continuous glucose monitor
What this could lead to
If successful, this could show that an automated insulin pump system is safe for very young children with type 1 diabetes, potentially improving their blood sugar control and reducing daily management burden.
What could go wrong
This is a small, completed safety study with only 56 children and no control group. It does not prove the system works better than other treatments, and risks like severe low blood sugar or device issues remain possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, 80045, United States
-
Nemours Childrens Specialty Care
Jacksonville, Florida, 32207, United States
-
Stanford University
Palo Alto, California, 94304, United States
-
Texas Childrens Hospital
Houston, Texas, 77030, United States
-
UCSF The Madison Clinic for Pediatric Diabetes
San Francisco, California, 94158, United States
-
USF Diabetes and Endocrinology Center
Tampa, Florida, 33612, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
Yale School of Medicine
New Haven, Connecticut, 06511, United States